Competitive Intelligence, Life Sciences, Research and Information Services
As pharmaceutical companies navigate pricing and market competition, discount analysis serves as a strategic compass. By unveiling critical insights into discount dynamics, pharmaceutical companies can shape their pricing strategies, market positioning, and financial planning. From calculating average discounts across therapeutic areas to identifying trends specific to public and private healthcare institutions, discount analysis is an indispensable tool for pharmaceutical companies that seek a competitive edge.
When a leading pharmaceutical company wanted to unravel the intricate dynamics of discounting within the pharmaceutical sector, they partnered with Netscribes. Explore how we provided them with actionable insights for navigating the competitive landscape with a finely tuned pricing strategy.
Our client, a leading pharmaceutical company, sought assistance in conducting a comprehensive study to analyze the discount rates being offered on ethical products across the value chain.
The main aim of this competitive research was to calculate the average discounts provided by various pharmaceutical companies in the target countries on their ethical products. The focus would lie on the top five therapeutic areas/product lines across the top five multinational pharmaceutical companies to arrive at the average.
These five pharmaceutical companies would be of similar employee strength and client size in terms of revenue. The target therapeutic areas were acute and chronic pain, antibiotics (Oral and Injectable), anti-coagulants, oral anti-diabetics, and respiratory – Antiasthmatic & COPD. The study spanned five countries, namely, Indonesia, Philippines, Singapore, Thailand, and Vietnam.
Netscribes used a fusion of extensive secondary and primary research to gather accurate insights on the discounts offered across these geographies.
After gathering data-rich insights about the prevalent discount dynamics across the competitive landscape, Netscribes provided a detailed report with the following key highlights: